Your browser doesn't support javascript.
loading
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia.
Lopez-Millan, Belen; Sanchéz-Martínez, Diego; Roca-Ho, Heleia; Gutiérrez-Agüera, Francisco; Molina, Oscar; Diaz de la Guardia, Rafael; Torres-Ruiz, Raúl; Fuster, Jose Luís; Ballerini, Paola; Suessbier, Ute; Nombela-Arrieta, Cesar; Bueno, Clara; Menéndez, Pablo.
Afiliación
  • Lopez-Millan B; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain. blopez@carrerasresearch.org.
  • Sanchéz-Martínez D; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.
  • Roca-Ho H; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.
  • Gutiérrez-Agüera F; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.
  • Molina O; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.
  • Diaz de la Guardia R; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.
  • Torres-Ruiz R; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.
  • Fuster JL; Molecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
  • Ballerini P; Pediatric Hematology and Oncology Section, Hospital Clínico Virgen de la Arrixaca, Murcia, Spain.
  • Suessbier U; Pediatric Hematology, Armand Trousseau Hospital, Paris, France.
  • Nombela-Arrieta C; Hematology Department, University Hospital-University of Zurich, Zurich, Switzerland.
  • Bueno C; Hematology Department, University Hospital-University of Zurich, Zurich, Switzerland.
  • Menéndez P; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain. cbueno@carrerasresearch.org.
Leukemia ; 33(7): 1557-1569, 2019 07.
Article en En | MEDLINE | ID: mdl-30635633
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteoglicanos / Linfocitos B / Reordenamiento Génico / Protocolos de Quimioterapia Combinada Antineoplásica / N-Metiltransferasa de Histona-Lisina / Resistencia a Antineoplásicos / Proteína de la Leucemia Mieloide-Linfoide / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antígenos Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteoglicanos / Linfocitos B / Reordenamiento Génico / Protocolos de Quimioterapia Combinada Antineoplásica / N-Metiltransferasa de Histona-Lisina / Resistencia a Antineoplásicos / Proteína de la Leucemia Mieloide-Linfoide / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antígenos Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article